FDA proposes stronger warning labels on OTC painkillers

The FDA began a proceeding aimed at requiring makers of over-the-counter painkillers to add more cautionary warnings to their labels. The labeling suggestions would vary according to the type of painkiller, including the potential for stomach bleeding with aspirin, ibuprofen and other NSAIDs and the potential for liver damage associated with acetaminophen.

View Full Article in:

USA Today · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC